Artia Global Partners »

Avalo Therapeutics Ord shares owned by Artia Global Partners

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $755k 42k 18.16

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Argenx Se Sponsored Adr (ARGX)
Eli Lilly & Co. (LLY)
Proshares Tr Ii Ultra Gold (UGL)
Soleno Therapeutics (SLNO)
Viking Therapeutics (VKTX)
Trevi Therapeutics (TRVI)
Uniqure Nv SHS (QURE)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Astrazeneca Sponsored Adr
Cidara Therapeutics Com New (CDTX)
Eyepoint Pharmaceuticals Com New (EYPT)
Ionis Pharmaceuticals (IONS)
Dianthus Therapeutics (DNTH)

View all positions for Artia Global Partners

Top funds holding Avalo Therapeutics Ord

BVF
Nantahala Capital Management
OrbiMed Advisors
Affinity Asset Advisors
Caligan Partners
Balyasny Asset Management
Vanguard Group
RA Capital Management
Point72 Asset Management
Silverarc Capital Management
Marshall Wace
Citadel Advisors
Commodore Capital
TCG Crossover Management
UBS Group

View all funds holding Avalo Therapeutics Ord